Cargando…
Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone
Treatment of pelvic neoplasms with radiotherapy may develop sequelae, especially RHC. An 85-year-old male patient was admitted to a hospital emergency with gross hematuria leading to urinary retention and was diagnosed with RHC. The urinary bladder was probed, unobstructed, and maintained in continu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497605/ https://www.ncbi.nlm.nih.gov/pubmed/28713429 http://dx.doi.org/10.1155/2017/1560363 |
_version_ | 1783248177155014656 |
---|---|
author | Nascimento, José Carlos Rodrigues Campelo, Márcio Wilker Soares Aragão, Iuri Arruda de Moura, José Fernando Bastos Silva, Lúcio Flávio Gonzaga Oriá, Reinaldo Barreto |
author_facet | Nascimento, José Carlos Rodrigues Campelo, Márcio Wilker Soares Aragão, Iuri Arruda de Moura, José Fernando Bastos Silva, Lúcio Flávio Gonzaga Oriá, Reinaldo Barreto |
author_sort | Nascimento, José Carlos Rodrigues |
collection | PubMed |
description | Treatment of pelvic neoplasms with radiotherapy may develop sequelae, especially RHC. An 85-year-old male patient was admitted to a hospital emergency with gross hematuria leading to urinary retention and was diagnosed with RHC. The urinary bladder was probed, unobstructed, and maintained in continuous three-way saline irrigation. During 45 days of hospitalization, the patient underwent two cystoscopic procedures for urinary bladder flocculation, whole blood transfusions, and one platelet apheresis. None of these interventions led to clinical resolution. As the patient hematological condition was deteriorating, dexamethasone (4 mg i.v., bolus of 6/6, 12/12, and 24 h during five days) and epoetin alpha (1000 IU, 1 ml, s.c., for four weeks) were administered which led to the remission of the urinary bleeding. Dexamethasone therapy may be considered for RHC, when conventional treatments are not effective or are not possible, avoiding more aggressive interventions such as cystectomy. |
format | Online Article Text |
id | pubmed-5497605 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-54976052017-07-16 Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone Nascimento, José Carlos Rodrigues Campelo, Márcio Wilker Soares Aragão, Iuri Arruda de Moura, José Fernando Bastos Silva, Lúcio Flávio Gonzaga Oriá, Reinaldo Barreto Case Rep Med Case Report Treatment of pelvic neoplasms with radiotherapy may develop sequelae, especially RHC. An 85-year-old male patient was admitted to a hospital emergency with gross hematuria leading to urinary retention and was diagnosed with RHC. The urinary bladder was probed, unobstructed, and maintained in continuous three-way saline irrigation. During 45 days of hospitalization, the patient underwent two cystoscopic procedures for urinary bladder flocculation, whole blood transfusions, and one platelet apheresis. None of these interventions led to clinical resolution. As the patient hematological condition was deteriorating, dexamethasone (4 mg i.v., bolus of 6/6, 12/12, and 24 h during five days) and epoetin alpha (1000 IU, 1 ml, s.c., for four weeks) were administered which led to the remission of the urinary bleeding. Dexamethasone therapy may be considered for RHC, when conventional treatments are not effective or are not possible, avoiding more aggressive interventions such as cystectomy. Hindawi 2017 2017-06-21 /pmc/articles/PMC5497605/ /pubmed/28713429 http://dx.doi.org/10.1155/2017/1560363 Text en Copyright © 2017 José Carlos Rodrigues Nascimento et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Nascimento, José Carlos Rodrigues Campelo, Márcio Wilker Soares Aragão, Iuri Arruda de Moura, José Fernando Bastos Silva, Lúcio Flávio Gonzaga Oriá, Reinaldo Barreto Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone |
title | Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone |
title_full | Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone |
title_fullStr | Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone |
title_full_unstemmed | Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone |
title_short | Treatment of Severe Refractory Hematuria due to Radiation-Induced Hemorrhagic Cystitis with Dexamethasone |
title_sort | treatment of severe refractory hematuria due to radiation-induced hemorrhagic cystitis with dexamethasone |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5497605/ https://www.ncbi.nlm.nih.gov/pubmed/28713429 http://dx.doi.org/10.1155/2017/1560363 |
work_keys_str_mv | AT nascimentojosecarlosrodrigues treatmentofsevererefractoryhematuriaduetoradiationinducedhemorrhagiccystitiswithdexamethasone AT campelomarciowilkersoares treatmentofsevererefractoryhematuriaduetoradiationinducedhemorrhagiccystitiswithdexamethasone AT aragaoiuriarruda treatmentofsevererefractoryhematuriaduetoradiationinducedhemorrhagiccystitiswithdexamethasone AT demourajosefernandobastos treatmentofsevererefractoryhematuriaduetoradiationinducedhemorrhagiccystitiswithdexamethasone AT silvalucioflaviogonzaga treatmentofsevererefractoryhematuriaduetoradiationinducedhemorrhagiccystitiswithdexamethasone AT oriareinaldobarreto treatmentofsevererefractoryhematuriaduetoradiationinducedhemorrhagiccystitiswithdexamethasone |